These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 10357639

  • 1. Attention-deficit-hyperactivity disorder.
    Diller LH.
    N Engl J Med; 1999 Jun 03; 340(22):1766; author reply 1767. PubMed ID: 10357639
    [No Abstract] [Full Text] [Related]

  • 2. [The use of methylphenidate in children with ADHD].
    Lauth B.
    Laeknabladid; 2007 Dec 03; 93(12):823. PubMed ID: 18057471
    [No Abstract] [Full Text] [Related]

  • 3. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
    't Jong GW, van den Anker JN.
    Ned Tijdschr Geneeskd; 2000 Nov 11; 144(46):2227-8. PubMed ID: 11103263
    [No Abstract] [Full Text] [Related]

  • 4. [Off-label use: the case of methylphenidate (Ritalin)].
    Fritze J, Schmauss M.
    Nervenarzt; 2002 Dec 11; 73(12):1210-2. PubMed ID: 12599339
    [No Abstract] [Full Text] [Related]

  • 5. ADHD drugs and cardiovascular risk.
    Wojnowski L.
    N Engl J Med; 2006 May 25; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729376
    [No Abstract] [Full Text] [Related]

  • 6. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R, Gross-Tsur V.
    Harefuah; 1997 May 01; 132(9):672-5. PubMed ID: 9225587
    [No Abstract] [Full Text] [Related]

  • 7. Evidence and belief in attention deficit hyperactivity disorder. Reintroduction of methylphenidate in Italy needs careful monitoring.
    Bonati M, Impicciatore P, Pandolfini C.
    BMJ; 2001 Mar 03; 322(7285):556. PubMed ID: 11263458
    [No Abstract] [Full Text] [Related]

  • 8. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H.
    Med Monatsschr Pharm; 2006 Nov 03; 29(11):415-6. PubMed ID: 17131689
    [No Abstract] [Full Text] [Related]

  • 9. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P, Weizman A.
    Psychosomatics; 2009 Nov 03; 50(2):178. PubMed ID: 19377031
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract] [Full Text] [Related]

  • 12. Pushing pills on kids? Lawyers claim a conspiracy to oversell Ritalin.
    Shute N.
    US News World Rep; 2000 Oct 02; 129(13):60. PubMed ID: 11183332
    [No Abstract] [Full Text] [Related]

  • 13. ADHD, Ritalin, and big brother.
    Miller AL.
    Altern Med Rev; 2000 Oct 02; 5(5):401. PubMed ID: 11056410
    [No Abstract] [Full Text] [Related]

  • 14. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B.
    Pediatrics; 2006 Sep 02; 118(3):e704-10. PubMed ID: 16950962
    [Abstract] [Full Text] [Related]

  • 15. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A, Yamashita Y, Koeda T, Hiratani M, Kaneko M, Yamada S, Matsuishi T.
    Ann Neurol; 2002 Sep 02; 52(3):372-4. PubMed ID: 12205654
    [Abstract] [Full Text] [Related]

  • 16. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD, Sverd J.
    Adv Neurol; 2006 Sep 02; 99():197-207. PubMed ID: 16536367
    [No Abstract] [Full Text] [Related]

  • 17. Methylphenidate.
    St Dennis C, Synoground G.
    J Sch Nurs; 1996 Feb 02; 12(1):5-8, 10-1. PubMed ID: 8696016
    [No Abstract] [Full Text] [Related]

  • 18. Drugs and children.
    Pinkham JR.
    ASDC J Dent Child; 2002 Feb 02; 69(1):10. PubMed ID: 12119805
    [No Abstract] [Full Text] [Related]

  • 19. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
    Strawn MN.
    J Contemp Health Law Policy; 2003 Feb 02; 19(2):495-520. PubMed ID: 14748255
    [No Abstract] [Full Text] [Related]

  • 20. Zeroing in on attention deficit disorder.
    Health News; 1999 Feb 01; 5(2):7. PubMed ID: 9972114
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.